Am. J. Respir. Crit. Care Med., Volume 164, Number 10, November 2001, 1805-1809

Longitudinal Changes in Physiological, Radiological, and Health Status Measurements in ₁-Antitrypsin Deficiency and Factors Associated with Decline

LEE J. DOWSON, PETER J. GUEST, and ROBERT A. STOCKLEY

Lung Investigation Unit, Nuffield House, Queen Elizabeth Hospital, University Hospital Birmingham NHS Trust, Birmingham, United Kingdom

The FEV₁ declines rapidly in ₁-antitrypsin deficiency (₁-ATD) but less is known about other measures of disease severity and the factors, other than smoking, that are associated with progression of emphysema. The natural history of ₁-ATD was studied prospectively in 43 patients with the PiZ phenotype and emphysema at a single center over 2 yr. The mean ± SE change in FEV₁ was 67 ± 14 ml/yr, accompanied by a reduction in transfer factor (mean change in diffusing capacity of the lung for CO [DL_CO] -1.07 ± 0.21 ml/min/mm Hg/yr; p < 0.001) and lung density in the upper zones as assessed by quantitative high-resolution computed tomography (HRCT) (mean change in voxel index 2.8 ± 0.6%/yr; p < 0.001). The decline in FEV₁ related to baseline FEV₁ (r = 0.56, p < 0.001), bronchodilator reversibility (r = 0.52, p < 0.001), and (for patients with FEV₁ > 35% predicted) exacerbation frequency (r = 0.38, p = 0.02). There was also a decline in the St. George's Respiratory Questionnaire (SGRQ) Activity score (mean change 4.3 ± 1.2 units/yr, p < 0.001) that correlated with FEV₁ decline (r = 0.45, p = 0.002). Progression of emphysema in ₁-ATD is dependent on baseline physiology and exacerbation frequency and may be detected by several different measurements of which HRCT density mask analysis and DL_CO appear most sensitive.

This article has been cited by other articles:

				G. E. Silva, S. Guerra, S. Keim, R. A. Barbee, and D. L. Sherrill Longitudinal Decline of Diffusing Capacity of the Lung for Carbon Monoxide in Community Subjects With the PiMZ {alpha}1-Antitrypsin Phenotype Chest, May 1, 2008; 133(5): 1095 - 1100. [Abstract] [Full Text] [PDF]

				M. Cazzola, W. MacNee, F. J. Martinez, K. F. Rabe, L. G. Franciosi, P. J. Barnes, V. Brusasco, P. S. Burge, P. M. A. Calverley, B. R. Celli, et al. Outcomes for COPD pharmacological trials: from lung function to biomarkers Eur. Respir. J., February 1, 2008; 31(2): 416 - 469. [Abstract] [Full Text] [PDF]

				K. Vijayasaratha and R. A. Stockley Reported and Unreported Exacerbations of COPD: Analysis by Diary Cards Chest, January 1, 2008; 133(1): 34 - 41. [Abstract] [Full Text] [PDF]

				H. Abusriwil and R. A. Stockley The Interaction of Host and Pathogen Factors in Chronic Obstructive Pulmonary Disease Exacerbations and Their Role in Tissue Damage Proceedings of the ATS, December 1, 2007; 4(8): 611 - 617. [Abstract] [Full Text] [PDF]

				J. P. de Torres, G. Bastarrika, J. P. Wisnivesky, A. B. Alcaide, A. Campo, L. M. Seijo, J. C. Pueyo, A. Villanueva, M. D. Lozano, U. Montes, et al. Assessing the Relationship Between Lung Cancer Risk and Emphysema Detected on Low-Dose CT of the Chest Chest, December 1, 2007; 132(6): 1932 - 1938. [Abstract] [Full Text] [PDF]

				J. Holme and R. A. Stockley Radiologic and Clinical Features of COPD Patients With Discordant Pulmonary Physiology: Lessons From {alpha}1-Antitrypsin Deficiency Chest, September 1, 2007; 132(3): 909 - 915. [Abstract] [Full Text] [PDF]

				J. Stolk, M. I. M. Versteegh, L. J. Montenij, M. E. Bakker, E. Grebski, M. Tutic, S. Wildermuth, W. Weder, M. el Bardiji, J. H. C. Reiber, et al. Densitometry for assessment of effect of lung volume reduction surgery for emphysema Eur. Respir. J., June 1, 2007; 29(6): 1138 - 1143. [Abstract] [Full Text] [PDF]

				W. R. Perera, J. R. Hurst, T. M. A. Wilkinson, R. J. Sapsford, H. Mullerova, G. C. Donaldson, and J. A. Wedzicha Inflammatory changes, recovery and recurrence at COPD exacerbation Eur. Respir. J., March 1, 2007; 29(3): 527 - 534. [Abstract] [Full Text] [PDF]

				D G Parr, B C Stoel, J Stolk, and R A Stockley Validation of computed tomographic lung densitometry for monitoring emphysema in {alpha}1-antitrypsin deficiency Thorax, June 1, 2006; 61(6): 485 - 490. [Abstract] [Full Text] [PDF]

				G C Donaldson and J A Wedzicha COPD exacerbations {middle dot} 1: Epidemiology Thorax, February 1, 2006; 61(2): 164 - 168. [Abstract] [Full Text] [PDF]

				G. B. Toews Impact of bacterial infections on airway diseases Eur. Respir. Rev., December 1, 2005; 14(95): 62 - 68. [Abstract] [Full Text] [PDF]

				P. J. Barnes New approaches to COPD Eur. Respir. Rev., September 1, 2005; 14(94): 2 - 11. [Abstract] [Full Text] [PDF]

				M. Needham and R. A. Stockley Exacerbations in {alpha}1-antitrypsin deficiency Eur. Respir. J., June 1, 2005; 25(6): 992 - 1000. [Abstract] [Full Text] [PDF]

				P. J. Barnes and R. A. Stockley COPD: current therapeutic interventions and future approaches Eur. Respir. J., June 1, 2005; 25(6): 1084 - 1106. [Abstract] [Full Text] [PDF]

				G. C. Donaldson, T. M. A. Wilkinson, J. R. Hurst, W. R. Perera, and J. A. Wedzicha Exacerbations and Time Spent Outdoors in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., March 1, 2005; 171(5): 446 - 452. [Abstract] [Full Text] [PDF]

				D. G. Parr, B. C. Stoel, J. Stolk, and R. A. Stockley Pattern of Emphysema Distribution in {alpha}1-Antitrypsin Deficiency Influences Lung Function Impairment Am. J. Respir. Crit. Care Med., December 1, 2004; 170(11): 1172 - 1178. [Abstract] [Full Text] [PDF]

				S B Shaker, T Stavngaard, J Stolk, B Stoel, and A Dirksen {alpha}1-Antitrypsin deficiency {middle dot} 7: Computed tomographic imaging in {alpha}1-antitrypsin deficiency Thorax, November 1, 2004; 59(11): 986 - 991. [Abstract] [Full Text] [PDF]

				D. G. Parr, B. C. Stoel, J. Stolk, P. G. Nightingale, and R. A. Stockley Influence of Calibration on Densitometric Studies of Emphysema Progression Using Computed Tomography Am. J. Respir. Crit. Care Med., October 15, 2004; 170(8): 883 - 890. [Abstract] [Full Text] [PDF]

				I. S. Patel, I. Vlahos, T. M. A. Wilkinson, S. J. Lloyd-Owen, G. C. Donaldson, M. Wilks, R. H. Reznek, and J. A. Wedzicha Bronchiectasis, Exacerbation Indices, and Inflammation in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., August 15, 2004; 170(4): 400 - 407. [Abstract] [Full Text] [PDF]

				J.D. Newell Jr, J.C. Hogg, and G.L. Snider Report of a workshop: quantitative computed tomography scanning in longitudinal studies of emphysema Eur. Respir. J., May 1, 2004; 23(5): 769 - 775. [Abstract] [Full Text] [PDF]

				M Needham and R A Stockley {alpha}1-Antitrypsin deficiency * 3: Clinical manifestations and natural history Thorax, May 1, 2004; 59(5): 441 - 445. [Abstract] [Full Text] [PDF]

				J Stolk, W H Ng, M E Bakker, J H C Reiber, K F Rabe, H Putter, and B C Stoel Correlation between annual change in health status and computer tomography derived lung density in subjects with {alpha}1-antitrypsin deficiency Thorax, December 1, 2003; 58(12): 1027 - 1030. [Abstract] [Full Text] [PDF]

				Poster presentations Thorax, December 1, 2002; 57(90003): iii48 - 94. [Full Text] [PDF]

				M. Miravitlles Exacerbations of chronic obstructive pulmonary disease: when are bacteria important? Eur. Respir. J., July 1, 2002; 20(36_suppl): 9S - 19s. [Abstract] [Full Text] [PDF]

				R. A. Stockley, D. L. Bayley, I. Unsal, and L. J. Dowson The Effect of Augmentation Therapy on Bronchial Inflammation in {alpha}1-Antitrypsin Deficiency Am. J. Respir. Crit. Care Med., June 1, 2002; 165(11): 1494 - 1498. [Abstract] [Full Text] [PDF]

				M. J. TOBIN Chronic Obstructive Pulmonary Disease, Pollution, Pulmonary Vascular Disease, Transplantation, Pleural Disease, and Lung Cancer in AJRCCM 2001 Am. J. Respir. Crit. Care Med., March 1, 2002; 165(5): 642 - 662. [Full Text] [PDF]